Panbio Covid-19 Ag Rapid Test

Manufactured by Abbott Rapid Diagnostics, Germany - https://www.globalpointofcare.abbott/en/index.html

Device identification number

1232

CE Marking

✓Yes

HSC common list (RAT)

✓Yes

Format

Manual, Near POC / POC

Physical Support

Cassette, Lateral flow

Target type

Antigen

Targets

nucleocapsid protein,

Specimen

Nasal swab, Nasopharyngeal swab

Cross-reactivity (pathogens tested)

SARS-CoV

Lineages detected

A.23.1 AT.1 B.1.1.7 (Alpha), B.1.351 (Beta), B.1.427 (Epsilon), B.1.429 (Epsilon), B.1.525 (Eta), B.1.526 (Iota), B.1.616 B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3 B.1.621 (Mu), C.36 C.37 (Lambda), P.1 (Gamma), P.2 (Zeta), P.3 (Theta), B.1.526.1 B.1.526.2 B.1.1.529 (Omicron),

Commercial Status

Commercialised

Last Update

2022-05-04 11:48:24 CET

Comments

Available for Professional use (Nasal and Nasopharyngeal) and Self-Test (Nasal)

Assay Type

Immuno-Antigen

Rapid Diagnostic

Yes

Self Test

Yes

Reader Required

Method

Immunochromatography

Measurement

Qualitative

Time

15 minutes

LOD

0 AU

Calibration

Evaluated

Crossreactivity

Evaluated

0 AU

Precision

Evaluated

Accuracy

100 %

Reproducibility

Not evaluated

Robustness

Evaluated

Clinical Sensitivity

98 %

Clinical Specificity

99 %

Type of antigen

Other

Related Scientific Literature

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements

COVID-19 In Vitro Diagnostic Medical Device - detail

Related Scientific Literature